Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
1.010
-0.200 (-16.53%)
At close: Nov 20, 2024, 4:00 PM
1.040
+0.030 (2.97%)
Pre-market: Nov 21, 2024, 6:19 AM EST
Jin Medical International Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 |
| Revenue | 20.13 | 19.82 | 19.19 | 20.76 | 16.19 | 20.37 | Upgrade
|
| Revenue Growth (YoY) | 0.75% | 3.29% | -7.58% | 28.22% | -20.49% | -2.61% | Upgrade
|
| Cost of Revenue | 13 | 12.86 | 12.83 | 14.18 | 10.7 | 12.86 | Upgrade
|
| Gross Profit | 7.13 | 6.96 | 6.36 | 6.59 | 5.5 | 7.51 | Upgrade
|
| Selling, General & Admin | 3.14 | 2.37 | 2.18 | 2.16 | 1.88 | 1.98 | Upgrade
|
| Research & Development | 1.52 | 1.54 | 1.89 | 1.57 | 1.26 | 1.13 | Upgrade
|
| Other Operating Expenses | 0.14 | 0.18 | 0.16 | 0.23 | - | - | Upgrade
|
| Operating Expenses | 4.8 | 4.1 | 4.23 | 3.95 | 3.14 | 3.11 | Upgrade
|
| Operating Income | 2.33 | 2.87 | 2.13 | 2.63 | 2.35 | 4.4 | Upgrade
|
| Interest Expense | - | - | - | -0.01 | -0.11 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.77 | 0.18 | 0.18 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.05 | 0.19 | 0.06 | -0.01 | -0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.16 | 0.22 | 0.2 | 0.19 | 0.12 | 0.08 | Upgrade
|
| EBT Excluding Unusual Items | 3.26 | 3.22 | 2.7 | 2.88 | 2.35 | 4.13 | Upgrade
|
| Pretax Income | 3.26 | 3.22 | 2.74 | 2.88 | 2.35 | 4.13 | Upgrade
|
| Income Tax Expense | 0.45 | 0.34 | 0.04 | 0.25 | 0.15 | 0.48 | Upgrade
|
| Net Income | 2.91 | 2.88 | 2.71 | 2.63 | 2.21 | 3.65 | Upgrade
|
| Net Income to Common | 2.91 | 2.88 | 2.71 | 2.63 | 2.21 | 3.65 | Upgrade
|
| Net Income Growth | -10.50% | 6.34% | 2.84% | 19.30% | -39.52% | -0.93% | Upgrade
|
| Shares Outstanding (Basic) | 156 | 145 | 135 | 135 | 400 | 400 | Upgrade
|
| Shares Outstanding (Diluted) | 156 | 145 | 135 | 135 | 400 | 400 | Upgrade
|
| Shares Change (YoY) | 15.26% | 7.51% | - | -66.25% | - | - | Upgrade
|
| EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | -22.35% | -1.08% | 2.84% | 253.54% | -39.53% | -0.93% | Upgrade
|
| Free Cash Flow | 0.23 | 2.99 | 1.54 | 5.8 | 2.36 | -1.4 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.02 | 0.01 | 0.04 | 0.01 | -0.00 | Upgrade
|
| Gross Margin | 35.43% | 35.14% | 33.13% | 31.72% | 33.95% | 36.88% | Upgrade
|
| Operating Margin | 11.55% | 14.47% | 11.10% | 12.67% | 14.54% | 21.62% | Upgrade
|
| Profit Margin | 14.44% | 14.52% | 14.10% | 12.67% | 13.62% | 17.91% | Upgrade
|
| Free Cash Flow Margin | 1.12% | 15.10% | 8.03% | 27.93% | 14.58% | -6.87% | Upgrade
|
| EBITDA | 2.56 | 3.09 | 2.49 | 2.98 | 2.68 | 4.75 | Upgrade
|
| EBITDA Margin | 12.70% | 15.61% | 12.99% | 14.34% | 16.58% | 23.34% | Upgrade
|
| D&A For EBITDA | 0.23 | 0.23 | 0.36 | 0.35 | 0.33 | 0.35 | Upgrade
|
| EBIT | 2.33 | 2.87 | 2.13 | 2.63 | 2.35 | 4.4 | Upgrade
|
| EBIT Margin | 11.55% | 14.47% | 11.10% | 12.67% | 14.54% | 21.62% | Upgrade
|
| Effective Tax Rate | 13.74% | 10.67% | 1.32% | 8.63% | 6.25% | 11.62% | Upgrade
|
| Revenue as Reported | 20.13 | 19.82 | 19.19 | 20.76 | 16.19 | 20.37 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.